The clinical and demographic characteristics of nonneuronopathic Gaucher disease in 887 children at diagnosis

被引:141
作者
Kaplan, Paige
Andersson, Hans C.
Kacena, Katherine A.
Yee, John D.
机构
[1] Univ Penn, Sch Med, Childrens Hosp Philadelphia, Dept Pediat,Sect Metab Dis, Philadelphia, PA USA
[2] Tulane Univ, Med Ctr, Hayward Genet Ctr, New Orleans, LA USA
[3] Genzyme Corp, Cambridge, MA USA
来源
ARCHIVES OF PEDIATRICS & ADOLESCENT MEDICINE | 2006年 / 160卷 / 06期
关键词
D O I
10.1001/archpedi.160.6.603
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Objective: To describe the clinical and demographic characteristics of nonneuronopathic Gaucher disease (GD) in children at the time of diagnosis. Design: Longitudinal observational database of the International Collaborative Gaucher Group Gaucher Registry. Setting: Data reported to the Registry from January 1, 1989, to June 3, 2005, were included in this report. Patients/Participants: All 887 patients were diagnosed as having nonneuronopathic GD from birth to younger than 18 years and did not receive enzyme replacement therapy. Main Outcome Measures: Eight measures of the clinical manifestations and demographics of nonneuronopathic GD. Results: The most common signs and symptoms noted were splenomegaly (95%), hepatomegaly (87%), radiologic bone disease (81%), thrombocytopenia (50%), anemia (40%), growth retardation (34%), bone pain (27%), and bone crisis (9%). Anemia and more severe splenomegaly and hepatomegaly were observed more frequently in younger patients. Skeletal manifestations were found more often in older children. Only 23% were identified as Ashkenazi Jews. Conclusions: Nonneuronopathic GD commonly manifests in childhood and affects many ethnic groups. The high prevalence of rare mutations may be associated with earlier onset and/or more severe disease. Increased awareness of the clinical and demographic characteristics of nonneuronopathic GD in children may improve early recognition of this treatable lysosomal storage disorder, decrease morbidity, and prevent irreversible sequelae.
引用
收藏
页码:603 / 608
页数:6
相关论文
共 17 条
[1]   REPLACEMENT THERAPY FOR INHERITED ENZYME DEFICIENCY - MACROPHAGE-TARGETED GLUCOCEREBROSIDASE FOR GAUCHERS-DISEASE [J].
BARTON, NW ;
BRADY, RO ;
DAMBROSIA, JM ;
DIBISCEGLIE, AM ;
DOPPELT, SH ;
HILL, SC ;
MANKIN, HJ ;
MURRAY, GJ ;
PARKER, RI ;
ARGOFF, CE ;
GREWAL, RP ;
YU, KT .
NEW ENGLAND JOURNAL OF MEDICINE, 1991, 324 (21) :1464-1470
[2]  
Beutler E., 2001, METABOLIC MOL BASES, V3, P3635
[3]  
BRADY RO, 1965, J BIOL CHEM, V240, P39
[4]   Enzyme replacement therapy and monitoring for children with type 1 Gaucher disease: Consensus recommendations [J].
Charrow, J ;
Andersson, HC ;
Kaplan, P ;
Kolodny, EH ;
Mistry, P ;
Pastores, G ;
Prakash-Cheng, A ;
Rosenbloom, BE ;
Scott, CR ;
Wappner, RS ;
Weinreb, NJ .
JOURNAL OF PEDIATRICS, 2004, 144 (01) :112-120
[5]   The Gaucher registry -: Demographics and disease characteristics of 1698 patients with Gaucher disease [J].
Charrow, J ;
Andersson, HC ;
Kaplan, P ;
Kolodny, EH ;
Mistry, P ;
Pastores, G ;
Rosenbloom, BE ;
Scott, CR ;
Wappner, RS ;
Weinreb, NJ ;
Zimran, A .
ARCHIVES OF INTERNAL MEDICINE, 2000, 160 (18) :2835-2843
[6]   Accuracy of ultrasonography in assessing spleen and liver size in patients with Gaucher disease: Comparison to computed tomographic measurements [J].
Elstein, D ;
HadasHalpern, I ;
Azuri, Y ;
Abrahamov, A ;
BarZiv, Y ;
Zimran, A .
JOURNAL OF ULTRASOUND IN MEDICINE, 1997, 16 (03) :209-211
[7]  
Grummer-Strawn, 2000, ADV DATA, V8, P1
[8]  
Hollander M., 1999, Nonparametric Statistical Methods
[9]   Acceleration of retarded growth in children with Gaucher disease after treatment with alglucerase [J].
Kaplan, P ;
Mazur, A ;
Manor, O ;
Charrow, J ;
Esplin, J ;
Gribble, TJ ;
Wappner, RS ;
Wisch, JS ;
Weinreb, NJ .
JOURNAL OF PEDIATRICS, 1996, 129 (01) :149-153
[10]  
Ludwig J., 1979, CURRENT METHODS AUTO, V2nd